Sumitomo Mitsui DS Asset Management Company Ltd Buys 8,378 Shares of Procter & Gamble Company (The) $PG

Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 1.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 593,845 shares of the company’s stock after purchasing an additional 8,378 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Procter & Gamble were worth $86,274,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of PG. Mowery & Schoenfeld Wealth Management LLC bought a new position in Procter & Gamble in the 2nd quarter worth approximately $26,000. Montgomery Financial Services LLC acquired a new position in Procter & Gamble during the 2nd quarter worth $28,000. Paladin Partners LLC acquired a new position in Procter & Gamble during the 2nd quarter worth $29,000. Sankala Group LLC acquired a new position in Procter & Gamble during the 4th quarter worth $30,000. Finally, Evergreen Advisors LLC bought a new position in Procter & Gamble in the 1st quarter valued at $37,000. 65.77% of the stock is owned by institutional investors.

Insider Activity at Procter & Gamble

In other news, CFO Andre Schulten sold 3,914 shares of the firm’s stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $568,860.76. Following the transaction, the chief financial officer directly owned 65,618 shares in the company, valued at $9,536,920.12. This trade represents a 5.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marc S. Pritchard sold 4,030 shares of Procter & Gamble stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total value of $579,473.70. Following the sale, the insider directly owned 187,001 shares of the company’s stock, valued at approximately $26,888,873.79. This trade represents a 2.11% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 15,135 shares of company stock worth $2,189,970. 0.23% of the stock is owned by company insiders.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Procter & Gamble’s decades-long record of dividend increases continues to support its appeal as a defensive income investment, particularly for investors seeking stability amid market and interest-rate volatility. Meet the Dividend King Stock That Yields More Than Quintuple the Nasdaq-100
• Positive Sentiment: PG is investing in brand innovation, artificial-intelligence capabilities and productivity programs designed to improve market share, margins and organic sales growth over the long term. Procter & Gamble’s Innovation Push
• Positive Sentiment: A new Head & Shoulders Scalp Care Collection gives the company a targeted, science-led product refresh that could help strengthen consumer engagement and support premium pricing in hair care. Why Is Procter & Gamble Refreshing Its Scalp Care Playbook Now?
• Neutral Sentiment: PG will report fiscal Q1 2027 results before the market opens on October 22. Investors are focused on organic sales, volumes, pricing, margins and management’s outlook for the remainder of fiscal 2027. Procter & Gamble Q1 Earnings Expectations
• Negative Sentiment: The immediate earnings tension is volume recovery versus pricing headwinds: stronger unit demand would be encouraging, but reduced pricing power could pressure revenue growth and profitability. Procter & Gamble Earnings Preview
• Negative Sentiment: With PG trading at roughly 24 times earnings and a high PEG ratio, investors may demand a strong outlook and clear evidence that innovation can revive growth; otherwise, the valuation leaves room for downside around the earnings event. Procter & Gamble Innovation and Valuation

Procter & Gamble Stock Down 1.1%

Shares of NYSE:PG opened at $157.59 on Tuesday. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.68 and a quick ratio of 0.47. The stock has a market cap of $366.02 billion, a price-to-earnings ratio of 23.80, a P/E/G ratio of 3.96 and a beta of 0.39. The company has a 50 day moving average of $147.11 and a 200-day moving average of $146.62. Procter & Gamble Company has a one year low of $137.62 and a one year high of $167.25.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business had revenue of $21.20 billion for the quarter, compared to analyst estimates of $21.38 billion. During the same period in the prior year, the business posted $1.48 earnings per share. Procter & Gamble’s revenue was up 1.5% compared to the same quarter last year. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, sell-side analysts forecast that Procter & Gamble Company will post 6.98 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. The ex-dividend date is Friday, October 23rd. This represents a $4.35 annualized dividend and a dividend yield of 2.8%. Procter & Gamble’s payout ratio is presently 65.71%.

Analysts Set New Price Targets

Several research firms have recently commented on PG. TD Cowen reissued a “hold” rating and issued a $150.00 target price on shares of Procter & Gamble in a research note on Wednesday, September 30th. Sanford C. Bernstein restated a “market perform” rating and set a $149.00 target price on shares of Procter & Gamble in a research report on Monday, August 24th. Argus lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Friday, August 7th. Barclays raised their price target on Procter & Gamble from $146.00 to $152.00 and gave the company an “equal weight” rating in a report on Tuesday, July 21st. Finally, Bank of America decreased their price target on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a report on Friday, July 10th. Fourteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average price target of $162.20.

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.